Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Abstract
Author summary: The use of biomarkers to measure immune responses in serum is crucial for understanding population-level exposure and susceptibility to human pathogens. Advances in sample collection, multiplex testing, and computational modeling are transforming serosurveillance into a powerful tool for public health program design and response to infectious threats. In July 2018, 70 scientists from 16 countries met to perform a landscape analysis of approaches that support an integrated serosurveillance platform, including the consideration of issues for successful implementation. Here, we summarize the group’s insights and proposed roadmap for implementation, including objectives, technical requirements, ethical issues, logistical considerations, and monitoring and evaluation.
Description
Acknowledgements: The “Expert Meeting on a platform for biomarker-based surveillance in communities to guide disease control interventions” was organized and supported by the Mérieux Foundation USA, with additional support from the Bill & Melinda Gates Foundation, the Coalition for Epidemic Preparedness Innovations (CEPI), the US Defense Threat Reduction Agency (DTRA), Luminex Corporation, and Spot On Sciences. This publication is a report on the Expert Meeting.

